A Dark Vector Cognition product

Item 6. Exhibits

10K characters. Original on sec.gov ·

Item 6. Exhibits

The 2 tables in Item 6. Exhibits as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

EXHIBITS

Exhibit 2. Separation and Distribution Agreement, dated November 7, 2022 by and between General Electric Company and GE HealthCare Technologies Inc. (f/k/a GE Healthcare Holding LLC), as amended (Incorporated by reference to Exhibit 2.1 to GE's Current Report on Form 8-K, dated January 4, 2023 (Commission file no. 001-00035)).†
Exhibit 10(a). Form of Agreement of Stock Option Grants to Executive Officers under the General Electric Company 2022 Long-Term Incentive Plan, as of March 2023.*
Exhibit 10(b). Form of Agreement for Restricted Stock Unit Grants to Executive Officers under the General Electric Company 2022 Long-Term Incentive Plan, as of March 2023.*
Exhibit 10(c). Form of Agreement for Performance Stock Unit Grants to Executive Officers under the General Electric Company 2022 Long-Term Incentive Plan, as of March 2023.*
Exhibit 10(d). Tax Matters Agreement, dated as of January 2, 2023, by and between General Electric Company and GE HealthCare Technologies Inc. (f/k/a GE Healthcare Holding LLC) (Incorporated by reference to Exhibit 10.1 to GE's Current Report on Form 8-K, dated January 4, 2023 (Commission file no. 001-00035)).†
Exhibit 11. Computation of Per Share Earnings. Data is provided in Note 18 of this Report.*
Exhibit 31(a). Certification Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended.*
Exhibit 31(b). Certification Pursuant to Rules 13a-14(a) or 15d-14(a) under the Securities Exchange Act of 1934, as Amended.*
Exhibit 32. Certification Pursuant to 18 U.S.C. Section 1350.*
Exhibit 101. The following materials from General Electric Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in XBRL (eXtensible Business Reporting Language); (i) Statement of Earnings (Loss) for the three months ended March 31, 2023 and 2022, (ii) Statement of Financial Position at March 31, 2023 and December 31, 2022, (iii) Statement of Cash Flows for the three months ended March 31, 2023 and 2022, (iv) Consolidated Statement of Comprehensive Income (Loss) for the three months ended March 31, 2023 and 2022, (v) Statement of Changes in Shareholders' Equity for the three months ended March 31, 2023 and 2022, and (vi) Notes to Consolidated Financial Statements.
Exhibit 104. Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
*Filed electronically herewith

†Certain portions of this exhibit have been redacted pursuant to Item 601(b)(2)(ii) and Item 601(b)(10)(iv) of Regulation S-K, as applicable. The Company agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon its request.

FORM 10-Q CROSS REFERENCE INDEXPage(s)
Part I – FINANCIAL INFORMATION
Item 1.Financial Statements20-44
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations4-19
Item 3.Quantitative and Qualitative Disclosures About Market Risk12, 42
Item 4.Controls and Procedures19
Part II – OTHER INFORMATION
Item 1.Legal Proceedings43-44
Item 1A.Risk FactorsNot applicable(a)
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds19
Item 3.Defaults Upon Senior SecuritiesNot applicable
Item 4.Mine Safety DisclosuresNot applicable
Item 5.Other InformationNot applicable
Item 6.Exhibits45
Signatures45

(a) For a discussion of our risk factors, refer to our Annual Report on Form 10-K for the year ended December 31, 2022.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

April 25, 2023/s/ Thomas S. Timko
DateThomas S. Timko Vice President, Chief Accounting Officer and Controller Principal Accounting Officer

2023 1Q FORM 10-Q 45

Previous: Item 1. Financial Statements